Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,968 | 230,784 | 85,262 | 284,309 | 43,728 |
| Marketable Securities | 406,752 | 135,563 | 257,007 | N/A | N/A |
| Receivables | 13,876 | N/A | N/A | N/A | N/A |
| Inventories | 3,321 | N/A | N/A | N/A | N/A |
| TOTAL | $562,330 | $375,274 | $347,874 | $289,368 | $45,071 |
| Non-Current Assets | |||||
| PPE Net | 2,285 | 208 | 20 | 57 | 77 |
| Intangibles | 15,630 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,543 | 566 | 1,168 | 396 | 513 |
| TOTAL | $20,458 | $774 | $1,188 | $453 | $590 |
| Total Assets | $582,788 | $376,048 | $349,062 | $289,821 | $45,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,262 | 2,576 | 260 | 1,744 | 202 |
| Accrued Expenses | 68,625 | 26,524 | 15,950 | 6,709 | 1,596 |
| TOTAL | $73,451 | $29,508 | $16,615 | $8,657 | $1,996 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,554 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,353 | 0 | 408 | 2,125 | 101,206 |
| TOTAL | $6,586 | $N/A | $408 | $16 | $97,870 |
| Total Liabilities | $80,037 | $29,508 | $17,023 | $8,673 | $99,866 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,355 | 87,385 | 73,587 | 61,952 | N/A |
| Common Shares | 10 | 9 | 7 | 6 | 2,000 |
| Retained earnings | -554,081 | -458,585 | -269,668 | -127,487 | -56,842 |
| Other shareholders' equity | 84 | 9 | -71 | 0 | 637 |
| TOTAL | $502,751 | $346,540 | $332,039 | $281,148 | $-54,205 |
| Total Liabilities And Equity | $582,788 | $376,048 | $349,062 | $289,821 | $45,661 |